99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW

Below are podcast interviews of individuals at UsAgainstAlzheimer’s that are recognized in the field and have been invited to share their expertise. Click Listen Now on the episodes of interest.